HuagongsheHuagongshe Chemistry Print Report · For research reference only
1-Ethyl-3-(3'-dimethylaminopropyl)carbodiimide → Letaxaban
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 1-Ethyl-3-(3'-dimethylaminopropyl)carbodiimide | HCID 15908 | — |
| Reactant | 1-Hydroxybenzotriazole | HCID 75771 | — |
| Reactant | 1-(Piperidin-4-yl)-1,3-diazinan-2-one | HCID 15572666 | — |
| Reactant | (2S)-3-[(6-chloro-2-naphthyl)sulfonyl]-2-hydroxypropionic acid | HCID 66854329 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | Letaxaban | HCID 11641515 | — |
Reaction Steps
(2S)-3-[(6-Chloronaphthalen-2-yl)sulfonyl]-2-hydroxypropionic acid, 1-(piperidin-4-yl)tetrahydropyrimidin-2(1H)-one, and HOBt were dissolved in DMF, WSC was added thereto, and the mixture was stirred at room temperature for 15 hours. The reaction mixture was concentrated under reduced pressure, diluted with an aqueous sodium bicarbonate solution, and extracted with dichloromethane. The extract was washed with an aqueous 5% citric acid solution and saturated saline solution, and dried over sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate to ethyl acetate/methanol=10/1) to obtain the title compound as a colorless powder.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08697865B2 |
| Source dataset | uspto-grants-2014_04 |
| ORD ID | ord-64b120ad09304fc9bc7a63417a459b58 |
| Source note | uspto-grants-2014_04 |